Effects of early enteral nutrition on Th17/Treg cells and IL-23/IL-17 in septic patients

Table 1 Demographic data and clinical parameters on admission

	EEN group	DEN group	P-value
	(n = 26)	(n = 27)
Age (yr)	58.85 ± 10.48	57.30 ± 14.82	0.663
Sex (Male:Female)	18:8	18:9	0.842
Etiology (n, %)
Abdominal infection	11 (42.3%)	14 (51.9%)	0.487
Thoracic/Pulmonary infection	10 (38.5%)	9 (33.3%)	0.697
Urinary infection	3 (11.5%)	2 (7.4%)	0.669
Mucocutaneous infection	2 (7.7%)	2 (7.4%)	1.000
BMI	25.25 ± 5.97	24.24 ± 4.15	0.476
APACHE II	21.69 ± 6.24	22.19 ± 5.69	0.765
SOFA	9.08 ± 1.94	9.44 ± 3.82	0.659

EEN: Early enteral nutrition; DEN: Delayed enteral nutrition; BMI: Body mass index; APACHE II: Acute physiology and chronic health evaluation II; SOFA: Sequential organ failure assessment.

Table 2 Clinical severity variables

		EEN group	DEN group	P-value
		(n = 26)	(n = 27)
APACHE II	Day 1	21.69 ± 6.24	22.19 ± 5.69	0.765
	Day 3	17.54 ± 26	19.04 ± 4.92	0.199
	Day 7	11.73 ± 4.82	15.11 ± 3.90	<0.001
SOFA	Day 1	9.08 ± 1.94	9.44 ± 3.82	0.659
	Day 3	6.31 ± 1.52	7.30 ± 3.30	0.132
	Day 7	3.58 ± 0.99	5.22 ± 2.33	<0.001
MV days		4.50 ± 2.58	7.15 ± 3.95	0.006
Number of CRRT (n, %)		4 (15.4%)	3 (11.1%)	0.704
ICU days		8.31 ± 4.26	11.22 ± 5.43	0.035

EEN: Early enteral nutrition; DEN: Delayed enteral nutrition; APACHE II: Acute physiology and chronic health evaluation II; SOFA: Sequential organ failure assessment; MV: Mechanical ventilation; CRRT: Continuous renal replacement therapy; ICU: Intensive care unit.